References

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

10.1016/s0140-6736(03)12113-7 · 2003 · External reference

Age-specific trends in the incidence and In-Hospital mortality of acute myocardial infarction over 30 years in Japan - Report from the Miyagi AMI registry study

10.1253/circj.cj-16-0799 · 2017 · External reference

Coronary heart disease in the framingham study

10.2105/ajph.47.4_pt_2.4 · 1957 · External reference

Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction

10.1001/jama.2011.1654 · 2011 · External reference

Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

10.1016/s0140-6736(21)00272-5 · 2021 · External reference

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry

10.1093/eurheartj/ehae299 · 2024 · External reference

Rationale, design, and baseline characteristics of the prospective japan acute myocardial infarction registry (JAMIR), cardiovasc

2019 · External reference

Third universal definition of myocardial infarction

10.1093/eurheartj/ehs184 · 2012 · External reference

Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-Year results from 37 WHO MONICA project populations

10.1016/s0140-6736(99)04021-0 · 1999 · External reference

The Japanese society of hypertension guidelines for the Management of Hypertension (JSH 2014)

10.1038/hr.2014.20 · 2014 · External reference

Executive summary of the Japan Atherosclerosis society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version

10.5551/jat.15792 · 2013 · External reference

International expert committee report on the role of the A1C assay in the diagnosis of diabetes

10.2337/dc09-9033 · 2009 · External reference

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium

10.1161/circulationaha.110.009449 · 2011 · External reference

Clinical characteristics and In-Hospital mortality according to left main and non-left main culprit lesions - report from the Japan acute myocardial infarction registry (JAMIR)

10.1253/circrep.cr-19-0056 · 2019 · External reference

Standard modifiable cardiovascular risk factors in patients with acute coronary syndrome: a report from multicenter percutaneous coronary intervention registry

10.1016/j.jjcc.2023.01.009 · 2023 · External reference

Coronary artery disease without standard cardiovascular risk factors

10.1016/j.amjcard.2021.10.032 · 2022 · External reference

Characteristics and outcomes of cardiac rupture in patients with ST-Segment elevation myocardial infarction

10.1253/circrep.cr-25-0196 · 2025 · External reference

Atrial fibrillation and the risk of myocardial infarction

10.1001/jamainternmed.2013.11912 · 2014 · External reference

Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism

10.1161/circulationaha.114.015134 · 2015 · External reference

Therapeutic inertia in statin therapy for secondary prevention after percutaneous coronary intervention: a nationwide population-based cohort study

10.1186/s12872-025-05081-0 · 2025 · External reference

International atherosclerosis society guidance for implementing best practice in the care of familial hypercholesterolaemia

10.1038/s41569-023-00892-0 · 2023 · External reference